LIP
LEGN icon

Lighthouse Investment Partners’s Legend Biotech LEGN Stock Holding History

Lighthouse Investment Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,880
Closed -$367K – 899
2025
Q4 		$367K Buy
+16,880
New +$484K 0.01% 653
2023
Q4 		– Sell
-23,975
Closed -$1.61M – 369
2023
Q3 		$1.61M Buy
+23,975
New +$1.67M 0.07% 256

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Lighthouse Investment Partners's LEGN Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 16,880 shares — an estimated $367K sold.

Lighthouse Investment Partners first reported a position in LEGN in Q3 2023 and held it in 2 quarters. The position peaked at $1.61M in Q3 2023. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 16,880 Legend Biotech shares in Q1 2026, an estimated $367K.
  • Lighthouse Investment Partners first reported a position in Legend Biotech in Q3 2023 and held it in 2 quarters.
  • Lighthouse Investment Partners's Legend Biotech position peaked at $1.61M in Q3 2023.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.